Document Detail


Counseling about risks of congenital anomalies from prescription opioids.
MedLine Citation:
PMID:  22847955     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The use of prescription opioids is becoming an increasing problem among women of reproductive age. More than half of pregnancies are unintended; therefore, many first-trimester exposures to opioids occur before pregnancy confirmation. Studies are limited about the fetal risks to opioid exposure in early pregnancy. One large study demonstrated an increased risk of certain heart defects and spina bifida with first-trimester exposure to opioids. It is important to counsel women whose fetuses were exposed to opioids in early pregnancy about the potential risks, encourage them to cease using opioids or seek alternative treatments when appropriate, and use the lowest effective dose when opioid treatment is to be continued. It is also valuable to screen for anatomic abnormalities such as neural tube and cardiac defects with available maternal serum testing and ultrasound imaging in the early second trimester. Birth Defects Research (Part A), 2012. © 2012 Wiley Periodicals, Inc..
Authors:
Matthew C Brennan; William F Rayburn
Related Documents :
11883355 - Rudimentary uterine horn pregnancy. the 20th-century worldwide experience of 588 cases.
6773995 - Sonographic characteristics of congenital uterine abnormalities and associated pregnancy.
10099765 - Rare delivery complication caused by an undiagnosed uterine septum.
17410585 - Sonographic diagnosis of uncomplicated first-trimester pregnancy in the rudimentary hor...
23928395 - Preeclampsia: an obstetrician's perspective.
16272815 - Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonogra...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-27
Journal Detail:
Title:  Birth defects research. Part A, Clinical and molecular teratology     Volume:  -     ISSN:  1542-0760     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101155107     Medline TA:  Birth Defects Res A Clin Mol Teratol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Affiliation:
Milagro Clinic for Pregnant Women with Substance Use Disorders, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque, New Mexico. MCBrennan@salud.unm.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DNA methylation alterations in response to pesticide exposure in vitro.
Next Document:  Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising anti...